Renaissance Technologies’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-219,140
| Closed | -$552K | – | 3852 |
|
|
2020
Q2 | $552K | Sell |
219,140
-20,800
| -9% | -$39.4K | ﹤0.01% | 2837 |
|
|
2020
Q1 | $307K | Buy |
239,940
+15,000
| +7% | +$30.6K | ﹤0.01% | 2971 |
|
|
2019
Q4 | $632K | Buy |
224,940
+62,125
| +38% | +$199K | ﹤0.01% | 2814 |
|
|
2019
Q3 | $866K | Buy |
162,815
+32,153
| +25% | +$214K | ﹤0.01% | 2654 |
|
|
2019
Q2 | $1.25M | Buy |
130,662
+19,303
| +17% | +$355K | ﹤0.01% | 2585 |
|
|
2019
Q1 | $2.98M | Sell |
111,359
-10,115
| -8% | -$257K | ﹤0.01% | 2111 |
|
|
2018
Q4 | $2.75M | Buy |
121,474
+77,813
| +178% | +$3.04M | ﹤0.01% | 2066 |
|
|
2018
Q3 | $2.41M | Buy |
43,661
+12,467
| +40% | +$796K | ﹤0.01% | 2186 |
|
|
2018
Q2 | $2.23M | Sell |
31,194
-16,415
| -34% | -$1.16M | ﹤0.01% | 2211 |
|
|
2018
Q1 | $2.92M | Buy |
47,609
+17,984
| +61% | +$1.58M | ﹤0.01% | 2120 |
|
|
2017
Q4 | $3.73M | Buy |
29,625
+12,946
| +78% | +$1.66M | ﹤0.01% | 1989 |
|
|
2017
Q3 | $2.28M | Buy |
16,679
+9,495
| +132% | +$1.27M | ﹤0.01% | 2233 |
|
|
2017
Q2 | $1.02M | Sell |
7,184
-50
| -0.7% | -$7.73K | ﹤0.01% | 2551 |
|
|
2017
Q1 | $1.33M | Sell |
7,234
-10,502
| -59% | -$1.18M | ﹤0.01% | 2435 |
|
|
2016
Q4 | $1.43M | Sell |
17,736
-18,714
| -51% | -$1.48M | ﹤0.01% | 2385 |
|
|
2016
Q3 | $2.79M | Sell |
36,450
-2,790
| -7% | -$224K | ﹤0.01% | 1996 |
|
|
2016
Q2 | $3.38M | Sell |
39,240
-9,720
| -20% | -$891K | 0.01% | 1872 |
|
|
2016
Q1 | $4.53M | Buy |
48,960
+29,257
| +148% | +$2.92M | 0.01% | 1704 |
|
|
2015
Q4 | $3.95M | Buy |
+19,703
| New | +$3.93M | 0.01% | 1646 |
|
|
2014
Q1 | – | Sell |
-1,375
| Closed | -$372K | – | 3098 |
|
|
2013
Q4 | $372K | Buy |
+1,375
| New | +$328K | ﹤0.01% | 2445 |
|
Renaissance Technologies's TTPH Position: Q3 2020 in Review
Renaissance Technologies sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 219,140 shares — an estimated $552K sold.
Renaissance Technologies first reported a position in TTPH in Q4 2013 and held it in 20 quarters. The position peaked at $4.53M in Q1 2016. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- Renaissance Technologies reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Renaissance Technologies sold 219,140 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $552K.
- Renaissance Technologies first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 20 quarters.
- Renaissance Technologies's Tetraphase Pharmaceuticals, Inc. position peaked at $4.53M in Q1 2016.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.